Johns Hopkins logo

Health Newsfeed

PSA SCREENING

ANCHOR LEAD: SHOULD MEN BE SCREENED FOR PROSTATE CANCER USING PSA TESTING?  ELIZABETH TRACEY REPORTS

Prostate cancer remains a killer, second only to lung cancer in claiming the lives of American men who die of cancer.  But now the American Cancer Society has issued new guidelines related to PSA or prostate specific antigen screening, calling for more judicious use of the test.  Arthur Burnett, a prostate cancer expert at Johns Hopkins, offers his view.

BURNETT:  My opinion on that is I largely support that we should not be using widespread PSA screening, I don’t think the data support that.  But I do think that patients at high risk, perhaps all men should have at least a discussion with their primary physician.  While PSA is an imperfect test it may be the best tool we have right now and indeed in those who are at high risk in particular, men who have a strong family history, those of an African American ancestry, these patients may be at a greater risk to develop prostate cancer and die from this disease.     :29

Research for more specific and predictive markers of aggressive disease is underway.  At Johns Hopkins, I’m Elizabeth Tracey.

 



Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home